Chad M Johannes, DVM, DACVIM (SAIM, Oncology)

Chad M. Johannes, DVM, DACVIM (SAIM, Oncology)

Position
  • Assistant Professor of Oncology
Chad M. Johannes, DVM, DACVIM (SAIM, Oncology) is an Assistant Professor of Oncology at Iowa State University. His industry experience includes former Medical Director at Aratana Therapeutics, Inc. and coordination of the launch of Palladia®, the first FDA-approved veterinary cancer therapeutic, during his time with Pfizer Animal Health (now Zoetis). Dr. Johannes’s practice experience includes primary care, specialty care and academic settings. His areas of research interest include oncology therapeutic development, immunotherapeutics and effective management of treatment-related side effects.

Contact Info

1569 LVMC
1809 S. Riverside Dr.
Ames
,
IA
50011-3619
Social Media and Websites

Education

  • B.S., Ag Honors/Vet Science, University of Nebraska-Lincoln, 1993
  • D.V.M., Kansas State University, 1997
  • Diplomate ACVIM (Small Animal Internal Medicine), 2002
  • Diplomate ACVIM (Oncology), 2013

More Information

NATIONAL ENGAGEMENT/ROLES

ACVIM Oncology Specialty President Elect, 2019 – present

Veterinary Cancer Society, Veterinary Oncology Market Potential Initiative Co-chair, 2018 – present

ACVIM Oncology Specialty Examination Rating Committee, 2017 – present

VMX (Orlando FL), Oncology CE Coordinator, April 2020 – present

USDA Center for Veterinary Biologics, Veterinary Oncology Technical Stakeholder Group, 2017 – present

 

ISU HONORS

Service Team of the Year Award (Oncology) – Iowa State University College of Veterinary Medicine, September 2019

Award for Early Achievement in Extension or Professional Practice – Iowa State University College of Veterinary Medicine, September 2019

Faculty Member of the Year – Iowa State University College of Veterinary Medicine, August 2017